drugset / Trial / NCT00468975
A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.
RandomizedCrossoverDouble-blindTreatment
Summary
A study to determine the ability of different doses of PF-610,355 to open the airways in asthmatic patients by comparison with placebo and a marketed drug that also opens the airways in asthmatic patients.
Timeline
- Start
- 2007-05
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-00610355 | Small molecule | — | — |
| Subject | Salmeterol | Other / unclassified | — | — |